Clinical Trial Update: A Study of MAX-40279combined With KN046 in Patients With Advanced / Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for MAX-40279 combined with KN046 in advanced/metastatic solid tumors (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• KN046
• MAX-40279

Snippet

Sponsor: Maxinovel Pty., Ltd. | Conditions: Advanced / Metastatic Solid Tumors | Phase 1, Phase 2 | Status: UNKNOWN